Invasiveness modulation of glioma cells by copper complex-loaded nanoarchitectures.

Copper complex Epithelial-to-mesenchymal transition Gold nanoparticles Invasiveness Metastasis Neuroglioma

Journal

Colloids and surfaces. B, Biointerfaces
ISSN: 1873-4367
Titre abrégé: Colloids Surf B Biointerfaces
Pays: Netherlands
ID NLM: 9315133

Informations de publication

Date de publication:
31 Aug 2024
Historique:
received: 23 02 2024
revised: 15 08 2024
accepted: 27 08 2024
medline: 8 9 2024
pubmed: 8 9 2024
entrez: 7 9 2024
Statut: aheadofprint

Résumé

Among the tumors with the highest lethality, gliomas are primary brain tumors associated with common recurrence inclined to metastasize along the neuraxis and occasionally out of the central nervous system. Even though metastasis is the main responsible for death in oncological patients, few dedicated treatments are approved. Therefore, the establishment of effective anti-metastasis agents is the final frontier in cancer research. Interestingly, some copper complexes have demonstrated promising efficacy as antimetastatic agents, but they may cause off-site effects such as the alteration of copper homeostasis in healthy tissues. Thus, the incorporation of copper-based antimetastatic agents in rationally designed nano-architectures can increase the treatment localization reducing the side effects. Here, copper complex loaded hybrid nano-architectures (CuLNAs) are presented and employed to assess the impact of an intracellular copper source on glioma cell invasiveness. The novel CuLNAs are fully characterized and exploited for cell migration modulation in a glioma cell line. The results demonstrate that CuLNAs significantly reduce cell migration without impairing cell proliferation compared to standard gold and copper NAs. A concomitant antimigratory-like regulation of the epithelial-to-mesenchymal transition genes confirmed these results, as the gene encoding for the epithelial protein E-cadherin was upregulated and the other explored mesenchymal genes were downregulated. These findings, together with the intrinsic behaviors of NAs, demonstrate that the inclusion of metal complexes in the nano-architectures is a promising approach for the composition of a family of agents with antimetastatic activity.

Identifiants

pubmed: 39243709
pii: S0927-7765(24)00446-6
doi: 10.1016/j.colsurfb.2024.114187
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114187

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The Authors declare no competing financial interests that could have appeared to influence the work reported in this paper.

Auteurs

Agata Zamborlin (A)

Center for Nanotechnology Innovation@ NEST, Istituto Italiano di Tecnologia, Piazza San Silvestro, 12, Pisa 56127, Italy; NEST-Scuola Normale Superiore, Piazza San Silvestro, 12, Pisa 56127, Italy.

Francesca Pagliari (F)

Division of BioMedical Physics in Radiation Oncology, German Cancer Research Center, Heidelberg 69120, Germany.

Maria Laura Ermini (ML)

Center for Nanotechnology Innovation@ NEST, Istituto Italiano di Tecnologia, Piazza San Silvestro, 12, Pisa 56127, Italy.

Valentina Frusca (V)

Center for Nanotechnology Innovation@ NEST, Istituto Italiano di Tecnologia, Piazza San Silvestro, 12, Pisa 56127, Italy; Scuola Superiore Sant'Anna, Piazza Martiri della Libertà, 33, Pisa 56127, Italy.

Daniel García-Calderón (D)

Division of BioMedical Physics in Radiation Oncology, German Cancer Research Center, Heidelberg 69120, Germany; Department of Physics and Astronomy, Heidelberg University, Im Neuenheimer Feld 227, Heidelberg 69120, Germany.

Luca Tirinato (L)

Division of BioMedical Physics in Radiation Oncology, German Cancer Research Center, Heidelberg 69120, Germany; Department of Medical and Surgical Science, University Magna Graecia, Catanzaro 88100, Italy.

Stefania Volante (S)

Department of Chemistry and Industrial Chemistry, University of Pisa, Via Moruzzi 13, Pisa 56124, Italy.

Giulio Bresciani (G)

Department of Chemistry and Industrial Chemistry, University of Pisa, Via Moruzzi 13, Pisa 56124, Italy.

Fabio Marchetti (F)

Department of Chemistry and Industrial Chemistry, University of Pisa, Via Moruzzi 13, Pisa 56124, Italy.

Joao Seco (J)

Division of BioMedical Physics in Radiation Oncology, German Cancer Research Center, Heidelberg 69120, Germany; Department of Physics and Astronomy, Heidelberg University, Im Neuenheimer Feld 227, Heidelberg 69120, Germany. Electronic address: j.seco@dkfz-heidelberg.de.

Valerio Voliani (V)

Center for Nanotechnology Innovation@ NEST, Istituto Italiano di Tecnologia, Piazza San Silvestro, 12, Pisa 56127, Italy; Department of Pharmacy, School of Medical and Pharmaceutical Sciences, University of Genoa, Viale Cembrano, 4, Genoa 16148, Italy. Electronic address: valerio.voliani@unige.it.

Classifications MeSH